Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa

World Journal of Biological Psychiatry

Volumn 11, Issue 6, 2010, Pages 824-833

  Kiezebrink, Kirsty ^a   Mann, Evleen T ^b   Bujac, Sarah R ^c   Stubbins, Michael J ^d   Campbell, David A ^e   Blundell, John E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SEACROFT HOSPITAL   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e A Unit of IMS   (United Kingdom)

Author keywords

Anorexia nervosa; Eating disorder; Genetics; Serotonin; Serotonin recpetor

Indexed keywords

SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY;

ADULT; ANOREXIA NERVOSA; BULIMIA NERVOSA; FEMALE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 77955634427     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.484550     Document Type: Article

References (61)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. DSM-IV Washington, DC: American Psychiatric Press.
2. Bergen AW, van Den Bree MBM, Yeager M, Welch R, Ganjei JK, Haque K, et al. 2003. Candidate genes for anorexia nervosa in the 1 p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 8(4):397-406.
3. Blundell JE. 1977. Is there a role for serotonin (5-hydroxytryp-tamine) in feeding. Int J Obes 1(1):15-42.
4. Blundell JE, Halford JCG. 1998. Serotonin and appetite regulation-Implications for the pharmacological treatment of obesity. CNS Drugs 9(6):473-495.
5. Boeler S, Williams C, Campling GM, Goodall EM, Cowen PJ. 1997. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women. Psychopharmacology 129(2):179-182.
6. Boules M, Cusack B, Zhao L, Fauq A, McCormick DJ, Richelson E. 2000. A novel neurotensin peptide analog given extracranially decreses food intake and weight in rodents. Brain Res 865:35-44.
7. Brewerton TD. 1995. Toward a unified theory of serotonin dysregulation in eating and realted disorders. Psychoneuroen-docrinology 20(6):561-590.
8. Brown KMO, Bujac SR, Mann ET, Campbell DA, Stubbins MJ, Blundell JE. 2007. Further evidence of association of OPRD1 and HTR1D polymorphisms with susceptibility to anorexia nervosa. Biol Psychiatry 61(3):367-373.
9. Clifton PG, Lee MD, Somerville EM, Kennett GA,Dourish CT. 2003. 5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function. Eur J Neurosci 17(1): 185-190.
10. 2C receptor supersensitiv-ity. Psychol Med 26:1155-1159.
11. Elfhag K, Linne Y. 2005. Gender differences in associations of eating pathology between mothers and their adolescent offspring. Obes Res 13(6):1070-1076.
12. Fairburn CG, Cowen PJ, Harrison PJ. 1999. Twins studies and the etiology of eating disorders. Int J Eat Disord 26:349-358.
13. Favaro A, Caregaro L, Burlina AB, Santonastaso P. 2000. Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosom Med 62(4):535-538.
14. Fichter M, Quadflieg N. 2001. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. Eur Psychiatry J Assoc Eur Psychiatr 16(1):38-48. (Pubitemid 32171331)
15. Fichter MM, Elton M, Engel K, Meyer AE, Mally H. 1991. Structured Interview for Anorexia and Bulimia Nervosa (SIAB). Development of a new instrument for the assessment of eating disorders. Int J Eat Disord 10:571-592.
16. Frank GK, Kaye WH, Weltzin TE, Perel J, Moss H, McConaha C, et al. 2001. Altered response to meta-chlorophenylpipera-zine in anorexia nervosa: Support for a persistent alteration of serotonin activity after short-term weight restoration. Int J Eat Disord 30(1):57-68.
17. Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C, et al. 2002. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 52(9): 896-906.
18. Garfinkel PE, Garner DM. 1982. Anorexia nervosa. A mulitidi-mensional perspective. New York: Brunner/Mazel.
19. Gorwood P. 2004. Eating disorders, serotonin transporter polymorphisms and potential treatment response. Am J Pharma-cogenomics 4(1):9-17.
20. Gorwood P, Kipman A, Foulon C. 2003. The human genetics of anorexia nervosa. Eur J Pharmacol 480(1-3):163-170.
21. Halford JCG. 2006. Pharmacotherapy for obesity. Appetite 46(1):6-10.
22. Halford JCG, Blundell JE. 1996. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol Behav 60(3):933-939.
23. Halford JCG, Blundell JE. 2000. Separate systems for serotonin and leptin in appetite control. Ann Med 32(3):222-232.
24. Halford JCG, Cooper GD, Dovey TM. 2004. The pharmacology of human appetite expression. Curr Drug Targets 5(3):221-240.
25. Halmi KA, Casper RC, Eckert ED, Goldberg SC, Davis JM. 1979. Unique features associated with age of onset of anorexia nervosa. Psychiatry Res 1:209-215.
26. Hebebrand J, Himmelmann GW, Heseker H, Schafer H, Remschmidt H. 1996. Use of percentiles for the body mass index in anorexia nervosa: Diagnostic, epidemiological and therapeutic considerations. Int J Eat Disord 19(4):359-369.
27. Hinney A, Barth N, Ziegler A, Von Prittwitz S, Hamann A, Hennighausen K, et al. 1997. Serotonin transporter gene-linked polymorphic region: Allele distributions in relationship to body weight and in anorexia nervosa. Life Sci. 61(21): PL295-303.
28. Hu X, Giotakis O, Li T, Karawautz A, Treasure J, Collier DA. 2003. Association of the 5-HT2c gene with susceptibility and minimum body mass index in anorexia nervosa. NeuroReport 14(6):781-783.
29. Jimerson DC, Lesem MD, Kaye WH, Hegg AP, Brewerton TD. 1990. Eating disorders and depression-Is there a serotonin connection. Biol Psychiatry 28(5):443-454.
30. Karwautz A, Rabe-Hesketh S, Hu X, Zhao J, Sham P, Collier DA, et al. 2001. Individual-specific risk factors for anorexia nervosa: a pilot study using a discordant sister-pair design. Psychol Med 31(2):317-329.
31. Kaye WH. 1997. Anorexia nervosa, obsessional behaviour, and serotonin. Psychopharmacol Bull 51:299-313.
32. Kaye WH, Gwirtsman HE, George DT, Ebert MH. 1991. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerobrospinal fluid 5-hydroxyindole-actic acid level correlate with rigid and obsessive behaviour? Arch Gen Psychiatry 48(6):556-562.
33. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, et al. 1998. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry 55(10):927-935.
34. Kaye WH, Nagata T, Weltzin TE, Hsu LG, Sokol MS, McConaha C, et al. 2001. Double-blind placebo-controlled administration of fluoxetine in restricting-and restricting-purg-ing-type anorexia nervosa. Biol Psychiatry 49(7):644-652.
35. Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, et al. 2003. Anxiolytic effects of acute tryp-tophan depletion in anorexia nervosa. Int J Eat Disord 33(3):257-267.
36. Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, et al. 2005. Serotonin alterations, in anorexia and bulimia nervosa: New insights from imaging studies. Physiol Behav 85(1):73-81.
37. Klump KL, Culbert KM. 2007. Molecular genetic studies of eating disorders-Current status and future directions. Curr Dir Psychol 16(1):37-41.
38. Klump KL, Gobrogge KL. 2005. A review and primer of molecular genetics. Int J Eat Disord 37:S43-48.
39. Lee Y, Lin P. 2009. Association between serotonin transporter gene polymorphism and eating disorders: A meta-analytic study. Int J Eat Disord in press.
40. Levitan RD, Kaplan AS, Masellis M, Basile VS, Walker ML, Lipson N, et al. 2001. Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 50(8):640-643.
41. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C, et al. 1998. A controlled family study of anorexia nervosa and bulimia nervosa-Psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 55(7):603-610.
42. Lucki I, Kreider MS, Simansky KJ. 1988. Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychop-harmacology 96:289-295.
43. Mehta CR, Patel NR. 1983. A network Algorithm for performing Fisher's Exact Test in r x c contingency tables. J Am Statist Assoc 78:427-434.
44. 2A receptor gene polymorphisms in anorexia ner-vosa and bulimia nervosa. Neurosci Lett 277(2):134-136.
45. Park S, Harrold JA, Widdowson PS, Williams G. 1999. Increased binding at 5-HT1A, 5-HT1B, and 5-HT2A receptors and 5-HT transporters in diet-induced obese rats. Brain Res 847(1):90-97.
46. Russo S, Kema IP, Bosker F, Haavik J, Korf J. 2007. Tryptophan as an evolutionarily conserved signal to brain serotonin: Molecular evidence and psychiatric implications. World J Biol Psychiatry 13:1-11.
47. Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ. 1997. 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 133(3):309-312.
48. Schosser A, Fuchs K, Scharl T, Schloegelhofer M, Kindler J, Mossaheb N, et al. 2008. Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry 1:1-8.
49. Simansky KJ, Nicklous DM. 2002. Parabrachial infusion of-fen-fluramine reduces food intake: Blockade by the 5-HT1B antagonist SB-216641. Pharmacol Biochem Behav 71(4):681-690.
50. Smith BM, Thomsen WJ, Grottick AJ. 2006. The potential use of selective 5-HT2C agonists in treating obesity. Invest Drugs 15(3):257-266.
51. Smith KA, Morris JS, Friston KJ, Cowen PJ, Dolan RJ. 1999. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 174:525-529.
52. Sokol MS, Carroll AK, Heebink DM, Hoffman-Rieken KM, Goudge CS, Ebers DD. 2009. Anorexia nervosa in identical triplets. CNS Spectrums 14(3):156-162.
53. Steiner M, Lepage P, Dunn EJ. 1997. Serotonin and gender-specific psychiatric disorders. Int J Psychiatry Clin Pract 1(1):3-13.
54. Steinhausen HC. 2002. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 159(8):1284-1293.
55. Sullivan PF. 1995. Mortality in anorexia nervosa. Am J Psychiatry 152:1073-1074.
56. 2C serotonin receptors. Nature 374: 542-546.
57. Treasure JL, Holland J. 1990. Genes and the aetiology of eating disorders. In: McGuffin P, Muray R, editors. The new genetics of mental illness. Oxford: Butterworth-Heinemann.
58. Van Der Ploeg LH. 2000. Obesity: an epidemic in need of therapeutics. Curr Opin Chem Biol 4(4):452-460.
59. Vandereycken W, Pierloot R. 1981. Anorexia nervosa in twins. Psychother Psychosom 35:5-63.
60. Westberg L, Bah J, Rastam M, Gillberg C, Wentz E, Melke J, et al. 2002. Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsy-chopharmacology 26(6):789-793.
61. Zaykin DV, Zhivotovsky LA, Weir BS. 1995. Exact tests for association between alleles at arbitrary numbers of loci. Genetica 96:169-178.